comparemela.com

Latest Breaking News On - Mesa laboratories - Page 1 : comparemela.com

Mesa Laboratories (NASDAQ:MLAB) Shares Down 5%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s share price fell 5% on Monday . The stock traded as low as $99.51 and last traded at $99.51. 16,576 shares were traded during trading, a decline of 63% from the average session volume of 44,738 shares. The stock had previously closed at $104.80. Wall Street Analyst […]

Louisiana
United-states
America
Asia-pacific
Entrypoint-capital
Calibration-solutions
Quadrant-capital-group
Nasdaq
Mesa-laboratories-inc
Jump-financial
Biopharmaceutical-development
Pricet-rowe-associates-inc

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Purchased by Ranger Investment Management L.P.

Ranger Investment Management L.P. boosted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,682 shares of the medical instruments supplier’s stock after buying an additional 2,689 shares […]

United-states
America
Asia-pacific
Nasdaq
King-luther-capital-management-corp
Mesa-laboratories-inc
Mesa-laboratories-company-profile
Quadrant-capital-group
Biopharmaceutical-development
Exchange-commission
Calibration-solutions
Comerica-bank

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 5.5%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price fell 5.5% during trading on Thursday . The company traded as low as $110.47 and last traded at $110.47. 17,348 shares changed hands during trading, a decline of 60% from the average session volume of 43,789 shares. The stock had previously closed at $116.84. Analyst […]

United-states
America
Asia-pacific
Calibration-solutions
Conestoga-capital-advisors
Mesa-laboratories-company-profile
Boone-capital-management
Mesa-laboratories-inc
Glenmede-trust-co
Biopharmaceutical-development
Comerica-bank
Motley-fool-asset-management

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

LAKEWOOD, Colo., May 31, 2024 Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously.

Mesa-laboratories-inc
Biopharmaceutical-development
Clinical-genomics
Mesa-laboratories

Jump Financial LLC Lowers Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Jump Financial LLC trimmed its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 25.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,468 shares of the medical instruments supplier’s stock after selling 825 shares during the period. Jump Financial LLC’s holdings in Mesa Laboratories were […]

United-states
Illinois
Louisiana
America
Asia-pacific
Mesa-laboratories-inc
Calibration-solutions
Jump-financial
Nasdaq
Motley-fool-asset-management
Illinois-municipal-retirement-fund
Biopharmaceutical-development

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.